IQVIA HOLDINGS INC. Payments to Acquire Available-for-sale Securities, Equity
IQVIA HOLDINGS INC. (IQV) reported Payments to Acquire Available-for-sale Securities, Equity of $13.20 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-02-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity · last filed 2015-02-12
- IQVIA HOLDINGS INC. payments to acquire available-for-sale securities, equity for the quarter ending 2012-12-31 was -$161.00K.
- IQVIA HOLDINGS INC. payments to acquire available-for-sale securities, equity for the quarter ending 2012-09-30 was $161.00K.
- IQVIA HOLDINGS INC. payments to acquire available-for-sale securities, equity for the quarter ending 2012-06-30 was $6.64M.
- IQVIA HOLDINGS INC. payments to acquire available-for-sale securities, equity for the quarter ending 2012-03-31 was $6.56M.
- IQVIA HOLDINGS INC. payments to acquire available-for-sale securities, equity for fiscal 2012 was $13.20M, a 17.75% decline from fiscal 2011.
- IQVIA HOLDINGS INC. payments to acquire available-for-sale securities, equity for fiscal 2011 was $16.05M.
| Period end | Payments to Acquire Available-for-sale Securities, Equity 3 month | Payments to Acquire Available-for-sale Securities, Equity 6 month | Payments to Acquire Available-for-sale Securities, Equity 9 month | Payments to Acquire Available-for-sale Securities, Equity 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $0.00 derived: sum of 2 quarters · filed 2015-02-12 | $6.64M derived: sum of 3 quarters · filed 2015-02-12 | $13.20M 10-K · filed 2015-02-12 |
| 2012-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $6.81M derived: sum of 2 quarters · filed 2013-10-31 | $13.37M 10-Q · filed 2013-10-31 | |
| 2012-06-30 | $6.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $13.20M 10-Q · filed 2013-08-01 | ||
| 2012-03-31 | $6.56M 10-Q · filed 2013-05-14 | |||
| 2011-12-31 | $16.05M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |